Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Nutr Soc ; 74(2): 125-9, 2015 May.
Article in English | MEDLINE | ID: mdl-25804507

ABSTRACT

The field of Mobile health (mHealth), which includes mobile phone applications (apps), is growing rapidly and has the potential to transform healthcare by increasing its quality and efficiency. The present paper focuses particularly on mobile technology for body weight management, including mobile phone apps for weight loss and the available evidence on their effectiveness. Translation of behaviour change theory into weight management strategies, including integration in mobile technology is also discussed. Moreover, the paper presents and discusses the myPace platform as a case in point. There is little clinical evidence on the effectiveness of currently available mobile phone apps in enabling behaviour change and improving health-related outcomes, including sustained body weight loss. Moreover, it is unclear to what extent these apps have been developed in collaboration with health professionals, such as dietitians, and the extent to which apps draw on and operationalise behaviour change techniques has not been explored. Furthermore, presently weight management apps are not built for use as part of dietetic practice, or indeed healthcare more widely, where face-to-face engagement is fundamental for instituting the building blocks for sustained lifestyle change. myPace is an innovative mobile technology for weight management meant to be embedded into and to enhance dietetic practice. Developed out of systematic, iterative stages of engagement with dietitians and consumers, it is uniquely designed to complement and support the trusted health practitioner-patient relationship. Future mHealth technology would benefit if engagement with health professionals and/or targeted patient groups, and behaviour change theory stood as the basis for technology development. Particularly, integrating technology into routine health care practice, rather than replacing one with the other, could be the way forward.


Subject(s)
Dietetics/methods , Energy Intake , Energy Metabolism , Mobile Applications , Overweight/prevention & control , Precision Medicine , Professional-Patient Relations , Behavior Therapy/methods , Behavior Therapy/trends , Combined Modality Therapy/methods , Combined Modality Therapy/trends , Congresses as Topic , Dietetics/trends , Humans , Mobile Applications/trends , Nutritionists , Overweight/diet therapy , Overweight/therapy , Professional Role , Technology Transfer , United Kingdom , Workforce
2.
Crit Rev Food Sci Nutr ; 55(13): 1918-28, 2015.
Article in English | MEDLINE | ID: mdl-24915414

ABSTRACT

Herbs, herbal extracts, or phytochemicals are broadly used as foods, drugs, and as traditional medicines. These are well regulated in Europe, with thorough controls on both safety and efficacy or validity of health claims. However, the distinction between medicines and foods with health claims is not always clear. In addition, there are several cases of herbal products that claim benefits that are not scientifically demonstrated. This review details the European Union (EU) legislative framework that regulates the approval and marketing of herbal products bearing health claims as well as the scientific evidence that is needed to support such claims. To illustrate the latter, we focus on phytoecdysteroid (PE)-containing preparations, generally sold to sportsmen and bodybuilders. We review the limited published scientific evidence that supports claims for these products in humans. In addition, we model the in silico binding between different PEs and human nuclear receptors and discuss the implications of these putative bindings in terms of the mechanism of action of this family of compounds. We call for additional research to validate the safety and health-promoting properties of PEs and other herbal compounds, for the benefit of all consumers.


Subject(s)
Herbal Medicine/methods , Phytotherapy , Plant Preparations/pharmacology , Animals , Consumer Product Safety/legislation & jurisprudence , Ecdysteroids/chemistry , Ecdysteroids/pharmacology , European Union/organization & administration , Herbal Medicine/legislation & jurisprudence , Humans , Mammals , Marketing/legislation & jurisprudence , Medicine, Traditional/methods , Models, Biological , Plants, Medicinal/chemistry
3.
Nutr Rev ; 69(1): 22-33, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21198632

ABSTRACT

Epidemiological and animal data show associations between whole grain and dietary fiber intakes and disease risk reduction. Dietary fiber can be considered a "black box" since its molecular structure can vary significantly. Limited data are available linking the health effects of dietary fiber to certain molecular structures. The present review was conducted to examine the existing knowledge of structure/effect relationships with a focus on human intervention studies that examined the relationships between the molecular structure of cereal dietary fiber and both the blood glucose and insulin responses and gut health. An extensive search of the existing literature was conducted using the PubMed database for the period 1993-2008. Of 48 publications originally identified using the search criteria, 13 provided molecular information in conjunction with fiber type. Several indications show a link between molecular structure and physiological effects. Limited data from human intervention trials are available to verify hypotheses derived from in vitro studies that relate the molecular structure of cereal dietary fiber to both insulin and glucose response and gut health.


Subject(s)
Blood Glucose/drug effects , Dietary Fiber/pharmacology , Edible Grain , Insulin/blood , Blood Glucose/metabolism , Dietary Fiber/administration & dosage , Digestive System Physiological Phenomena , Edible Grain/chemistry , Humans , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL